Swiss PharmaCan AG: Swiss Pharmacan's Supplement Authorized for Immediate Clinical Study to Confirm Effectiveness Against Long-COVID

FRAUENFELD, Switzerland, Dec. 21, 2021 /PRNewswire/ -- "The use of ArtemiC Support has shown clear improvement of [long-COVID] symptoms after just a few days," states research collaborator

Related Keywords

Switzerland ,Frauenfeld ,Thurgau ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Spanish ,Francisco Mera Cordero ,Mera Cordero ,Kostenloser Wertpapierhandel ,Mycell Technology ,Spanish Ethics Committee ,Research Center ,Catalan Health Authority ,Artemic Support ,Glow Lifetech ,Medical Research Center ,Post Covid Functional Score ,Cell Technology ,Swiss ,Harmacan ,Supplement ,Uthorized ,Immediate ,Linical ,Study ,Confirm ,Effectiveness ,Against ,Song ,Covid ,